| Year |
Citation |
Score |
| 2020 |
Alves MS, da Silva Cariolano M, Dos Santos Ferreira HL, Sousa de Abreu Silva E, Felipe KKP, Monteiro SG, de Sousa EM, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, de Paula Abreu Silva IC, Lima-Neto LG. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection. Brazilian Journal of Microbiology : [Publication of the Brazilian Society For Microbiology]. PMID 31997263 DOI: 10.1007/S42770-020-00229-W |
0.327 |
|
| 2015 |
Campbell LA, Rosenfeld ME. Infection and Atherosclerosis Development. Archives of Medical Research. PMID 26004263 DOI: 10.1016/J.Arcmed.2015.05.006 |
0.436 |
|
| 2014 |
Cabbage S, Ieronimakis N, Preusch M, Lee A, Ricks J, Janebodin K, Hays A, Wijelath ES, Reyes M, Campbell LA, Rosenfeld ME. Chlamydia pneumoniae infection of lungs and macrophages indirectly stimulates the phenotypic conversion of smooth muscle cells and mesenchymal stem cells: potential roles in vascular calcification and fibrosis. Pathogens and Disease. 72: 61-9. PMID 24833344 DOI: 10.1111/2049-632X.12185 |
0.433 |
|
| 2014 |
Campbell LA, Rosenfeld ME. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Frontiers in Cellular and Infection Microbiology. 4: 34. PMID 24711989 DOI: 10.3389/Fcimb.2014.00034 |
0.309 |
|
| 2013 |
Campbell LA, Lee AW, Rosenfeld ME, Kuo CC. Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1. Pathogens and Disease. PMID 23821487 DOI: 10.1111/2049-632X.12058 |
0.461 |
|
| 2012 |
Campbell LA, Puolakkainen M, Lee A, Rosenfeld ME, Garrigues HJ, Kuo CC. Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells. Microbes and Infection / Institut Pasteur. 14: 43-9. PMID 21911078 DOI: 10.1016/J.Micinf.2011.08.003 |
0.421 |
|
| 2011 |
Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thrombosis and Haemostasis. 106: 858-67. PMID 22012133 DOI: 10.1160/Th11-06-0392 |
0.431 |
|
| 2011 |
Campbell LA, Zidal SV, Patton D, Kuo C. O4-S2.03 An anti-adhesive approach to prevention of C trachomatis infection Sexually Transmitted Infections. 87: A86-A86. DOI: 10.1136/Sextrans-2011-050109.147 |
0.474 |
|
| 2010 |
Campbell LA, Yaraei K, Van Lenten B, Chait A, Blessing E, Kuo CC, Nosaka T, Ricks J, Rosenfeld ME. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Microbes and Infection / Institut Pasteur. 12: 598-606. PMID 20417302 DOI: 10.1016/J.Micinf.2010.04.001 |
0.39 |
|
| 2009 |
Campbell LA, Kuo CC. Cultivation and laboratory maintenance of Chlamydia pneumoniae. Current Protocols in Microbiology. Unit11B.1. PMID 19235146 DOI: 10.1002/9780471729259.Mc11B01S12 |
0.421 |
|
| 2008 |
Jiang SJ, Campbell LA, Berry MW, Rosenfeld ME, Kuo CC. Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis. Microbes and Infection / Institut Pasteur. 10: 1393-7. PMID 18678272 DOI: 10.1016/J.Micinf.2008.07.022 |
0.457 |
|
| 2008 |
Campbell LA, Kuo CC, Suchland RJ, Rothstein DM. Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection. Antimicrobial Agents and Chemotherapy. 52: 1855-8. PMID 18332169 DOI: 10.1128/Aac.01567-07 |
0.346 |
|
| 2008 |
Jiang SJ, Kuo CC, Berry MW, Lee AW, Campbell LA. Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages. Infection and Immunity. 76: 1558-64. PMID 18227157 DOI: 10.1128/Iai.01331-07 |
0.303 |
|
| 2008 |
Puolakkainen M, Lee A, Nosaka T, Fukushi H, Kuo CC, Campbell LA. Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors. Microbial Pathogenesis. 44: 410-6. PMID 18162363 DOI: 10.1016/J.Micpath.2007.11.004 |
0.39 |
|
| 2008 |
Takaoka N, Campbell LA, Lee A, Rosenfeld ME, Kuo CC. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo. Infection and Immunity. 76: 510-4. PMID 18070891 DOI: 10.1128/Iai.01267-07 |
0.456 |
|
| 2007 |
Kuo CC, Lee A, Jiang SJ, Yaraei K, Campbell LA. Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy. Microbes and Infection / Institut Pasteur. 9: 1139-41. PMID 17656142 DOI: 10.1016/J.Micinf.2007.04.014 |
0.435 |
|
| 2006 |
Rothstein DM, Shalish C, Murphy CK, Sternlicht A, Campbell LA. Development potential of rifalazil and other benzoxazinorifamycins. Expert Opinion On Investigational Drugs. 15: 603-23. PMID 16732714 DOI: 10.1517/13543784.15.6.603 |
0.375 |
|
| 2006 |
Campbell LA, Lee A, Kuo CC. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects infectivity in the mouse model of lung infection. Infection and Immunity. 74: 3027-9. PMID 16622244 DOI: 10.1128/Iai.74.5.3027-3029.2006 |
0.423 |
|
| 2005 |
Puolakkainen M, Kuo CC, Campbell LA. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infection and Immunity. 73: 4620-5. PMID 16040974 DOI: 10.1128/Iai.73.8.4620-4625.2005 |
0.437 |
|
| 2005 |
Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC, Rosenfeld ME. Effect of Chlamydia pneumoniae on cellular ATP content in mouse macrophages: role of Toll-like receptor 2. Infection and Immunity. 73: 4323-6. PMID 15972526 DOI: 10.1128/Iai.73.7.4323-4326.2005 |
0.439 |
|
| 2005 |
Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC, Rosenfeld ME. Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway. Infection and Immunity. 73: 4315-22. PMID 15972525 DOI: 10.1128/Iai.73.7.4315-4322.2005 |
0.457 |
|
| 2005 |
Blessing E, Campbell LA, Rosenfeld ME, Chesebro B, Kuo CC. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. The Journal of Antimicrobial Chemotherapy. 55: 1037-40. PMID 15845780 DOI: 10.1093/Jac/Dki128 |
0.422 |
|
| 2005 |
Campbell LA, Nosaka T, Rosenfeld ME, Yaraei K, Kuo CC. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Infection and Immunity. 73: 3164-5. PMID 15845526 DOI: 10.1128/Iai.73.5.3164-3165.2005 |
0.311 |
|
| 2004 |
Kuo CC, Lee A, Campbell LA. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells. Infection and Immunity. 72: 6699-701. PMID 15501806 DOI: 10.1128/Iai.72.11.6699-6701.2004 |
0.384 |
|
| 2004 |
Gold ES, Simmons RM, Petersen TW, Campbell LA, Kuo CC, Aderem A. Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages. The Journal of Experimental Medicine. 200: 581-6. PMID 15337791 DOI: 10.1084/Jem.20040546 |
0.383 |
|
| 2004 |
Campbell LA, Kuo CC. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? Nature Reviews. Microbiology. 2: 23-32. PMID 15035006 DOI: 10.1038/Nrmicro796 |
0.407 |
|
| 2003 |
Bea F, Blessing E, Bennett BJ, Kuo CC, Campbell LA, Kreuzer J, Rosenfeld ME. Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovascular Research. 60: 198-204. PMID 14522423 DOI: 10.1016/S0008-6363(03)00464-4 |
0.322 |
|
| 2003 |
Chesebro BB, Blessing E, Kuo CC, Rosenfeld ME, Puolakkainen M, Campbell LA. Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis. Cardiovascular Research. 60: 170-4. PMID 14522420 DOI: 10.1016/S0008-6363(03)00389-4 |
0.398 |
|
| 2003 |
Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Seminars in Respiratory Infections. 18: 48-54. PMID 12652454 DOI: 10.1053/Srin.2003.50006 |
0.452 |
|
| 2003 |
Bea F, Puolakkainen MH, McMillen T, Hudson FN, Mackman N, Kuo CC, Campbell LA, Rosenfeld ME. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circulation Research. 92: 394-401. PMID 12600889 DOI: 10.1161/01.Res.0000059982.43865.75 |
0.417 |
|
| 2003 |
Puolakkainen M, Campbell LA, Lin TM, Richards T, Patton DL, Kuo CC. Cell-to-cell contact of human monocytes with infected arterial smooth-muscle cells enhances growth of Chlamydia pneumoniae. The Journal of Infectious Diseases. 187: 435-40. PMID 12552427 DOI: 10.1086/368267 |
0.383 |
|
| 2003 |
Kuo CC, Campbell LA. Chlamydial infections of the cardiovascular system. Frontiers in Bioscience : a Journal and Virtual Library. 8: e36-43. PMID 12456307 DOI: 10.2741/859 |
0.455 |
|
| 2002 |
Blessing E, Campbell LA, Rosenfeld ME, Kuo CC. Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice. Infection and Immunity. 70: 5332-4. PMID 12183595 DOI: 10.1128/Iai.70.9.5332-5334.2002 |
0.424 |
|
| 2002 |
Campbell LA, Kuo CC. Chlamydia pneumoniae pathogenesis. Journal of Medical Microbiology. 51: 623-5. PMID 12171291 DOI: 10.1099/0022-1317-51-8-623 |
0.398 |
|
| 2002 |
Blessing E, Kuo CC, Lin TM, Campbell LA, Bea F, Chesebro B, Rosenfeld ME. Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines. Circulation. 105: 1976-82. PMID 11997286 DOI: 10.1161/01.Cir.0000015062.41860.5B |
0.408 |
|
| 2002 |
Kuo CC, Campbell LA, Rosenfeld ME. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. Circulation. 105: E34. PMID 11815446 DOI: 10.1161/Circ.105.4.E34 |
0.43 |
|
| 2002 |
Kuo CC, Puolakkainen M, Lin TM, Witte M, Campbell LA. Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microbial Pathogenesis. 32: 43-8. PMID 11782120 DOI: 10.1006/Mpat.2001.0479 |
0.401 |
|
| 2001 |
O'Connor S, Taylor C, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerging Infectious Diseases. 7: 780-8. PMID 11747688 DOI: 10.3201/Eid0705.010503 |
0.376 |
|
| 2001 |
Campbell LA, Roberts S, Inoue S, Kong L, Kuo Cc CC. Evaluation of Chlamydia pneumoniae 43- and 53-kilodalton recombinant proteins for serodiagnosis by Western Blot. Clinical and Diagnostic Laboratory Immunology. 8: 1231-3. PMID 11687468 DOI: 10.1128/Cdli.8.6.1231-1233.2001 |
0.426 |
|
| 2001 |
Blessing E, Campbell LA, Rosenfeld ME, Chough N, Kuo CC. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis. 158: 13-7. PMID 11500169 DOI: 10.1016/S0021-9150(00)00758-9 |
0.453 |
|
| 2001 |
Lin TM, Campbell LA, Rosenfeld ME, Kuo CC. Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae. The Journal of Infectious Diseases. 183: 1368-72. PMID 11294668 DOI: 10.1086/319870 |
0.403 |
|
| 2000 |
Blessing E, Nagano S, Campbell LA, Rosenfeld ME, Kuo CC. Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infection and Immunity. 68: 7195-7. PMID 11083855 DOI: 10.1128/Iai.68.12.7195-7197.2000 |
0.455 |
|
| 2000 |
Blessing E, Lin TM, Campbell LA, Rosenfeld ME, Lloyd D, Kuo C. Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infection and Immunity. 68: 4765-8. PMID 10899884 DOI: 10.1128/Iai.68.8.4765-4768.2000 |
0.407 |
|
| 2000 |
Campbell LA, Blessing E, Rosenfeld M, Lin Tm, Kuo C. Mouse models of C. pneumoniae infection and atherosclerosis. The Journal of Infectious Diseases. S508-13. PMID 10839749 DOI: 10.1086/315629 |
0.443 |
|
| 2000 |
Rosenfeld ME, Blessing E, Lin TM, Moazed TC, Campbell LA, Kuo C. Chlamydia, inflammation, and atherogenesis. The Journal of Infectious Diseases. 181: S492-7. PMID 10839746 DOI: 10.1086/315618 |
0.5 |
|
| 2000 |
Jackson LA, Campbell LA, Schmidt RA, Kuo C, Cappuccio AL, Lee MJ, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. The Journal of Infectious Diseases. 181: S447-8. PMID 10839735 DOI: 10.1086/315626 |
0.356 |
|
| 2000 |
Kuo CC, Campbell LA. Detection of Chlamydia pneumoniae in arterial tissues Journal of Infectious Diseases. 181. PMID 10839731 DOI: 10.1086/315615 |
0.404 |
|
| 2000 |
Campbell LA, Rosenfeld M, Kuo CC. The role of Chlamydia pneumoniae in atherosclerosis - Recent evidence from animal models Trends in Microbiology. 8: 255-257. PMID 10838578 DOI: 10.1016/S0966-842X(00)01745-5 |
0.482 |
|
| 2000 |
Lin TM, Campbell LA, Rosenfeld ME, Kuo CC. Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae Journal of Infectious Diseases. 181: 1096-1100. PMID 10720536 DOI: 10.1086/315349 |
0.416 |
|
| 1999 |
Campbell LA. How to design studies to confirm a link between bacterial infection and atherosclerosis. American Heart Journal. 138: S552-3. PMID 10539873 DOI: 10.1016/S0002-8703(99)70300-5 |
0.399 |
|
| 1999 |
Campbell LA, Kuo Cc. Mouse models of Chlamydia pneumoniae infection and atherosclerosis. American Heart Journal. 138: S516-8. PMID 10539863 DOI: 10.1016/S0002-8703(99)70290-5 |
0.437 |
|
| 1999 |
Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. The Journal of Infectious Diseases. 180: 238-41. PMID 10353889 DOI: 10.1086/314855 |
0.43 |
|
| 1999 |
Schaad HJ, Malinverni R, Campbell LA, Matter L. Myocardial infarction, culture-negative endocarditis, and Chlamydia pneumoniae infection: A dilemma? Clinical Infectious Diseases. 28: 162-163. PMID 10028104 DOI: 10.1086/517195 |
0.351 |
|
| 1999 |
Campbell LA, Kuo CC. Mouse models of Chlamydia pneumoniae infection and atherosclerosis American Heart Journal. 138. |
0.335 |
|
| 1998 |
Campbell LA, Kuo CC, Thomas Grayston J. Chlamydia pneumoniae and cardiovascular disease Emerging Infectious Diseases. 4: 571-579. PMID 9866733 DOI: 10.3201/Eid0404.980407 |
0.45 |
|
| 1998 |
Kuo CC, Campbell LA. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Molecular Medicine Today. 4: 426-430. PMID 9793930 DOI: 10.1016/S1357-4310(98)01351-3 |
0.491 |
|
| 1998 |
Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman WP, Finley JC, Grayston JT. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98: 628-33. PMID 9715854 DOI: 10.1161/01.Cir.98.7.628 |
0.38 |
|
| 1998 |
Campbell LA, Moazed TC, Kuo CC, Grayston JT. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: Hypercholesterolemic mice Clinical Microbiology and Infection. 4. DOI: 10.1111/J.1469-0691.1998.Tb00700.X |
0.484 |
|
| 1997 |
Kuo CC, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. Journal of Vascular Surgery. 26: 29-31. PMID 9240318 DOI: 10.1016/S0741-5214(97)70143-5 |
0.307 |
|
| 1997 |
Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis Journal of Infectious Diseases. 175: 883-890. PMID 9086145 DOI: 10.1086/513986 |
0.431 |
|
| 1997 |
Patton DL, Sweeney YC, Bohannon NJ, Clark AM, Hughes JP, Cappuccio A, Campbell LA, Stamm WE. Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. The Journal of Infectious Diseases. 175: 648-54. PMID 9041337 DOI: 10.1093/Infdis/175.3.648 |
0.351 |
|
| 1997 |
Puolakkainen M, Campbell LA, Kuo CC, Leinonen M, Grönhagen-Riska C, Saikku P. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. The Journal of Infection. 33: 199-205. PMID 8945710 DOI: 10.1016/S0163-4453(96)92273-2 |
0.415 |
|
| 1996 |
Moazed TC, Kuo CC, Patton DL, Grayston JT, Campbell LA. Experimental rabbit models of Chlamydia pneumoniae infection American Journal of Pathology. 148: 667-676. PMID 8579129 |
0.372 |
|
| 1995 |
Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews. 8: 451-461. PMID 8665464 DOI: 10.1128/Cmr.8.4.451-461.1995 |
0.452 |
|
| 1995 |
Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92: 3397-400. PMID 8521559 DOI: 10.1161/01.Cir.92.12.3397 |
0.323 |
|
| 1995 |
Malinverni R, Kuo CC, Campbell LA, Lee A, Grayston JT. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis Antimicrobial Agents and Chemotherapy. 39: 45-49. PMID 7695327 DOI: 10.1128/Aac.39.1.45 |
0.364 |
|
| 1995 |
Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proceedings of the National Academy of Sciences of the United States of America. 92: 6911-4. PMID 7624342 DOI: 10.1073/Pnas.92.15.6911 |
0.322 |
|
| 1995 |
Malinverni R, Kuo CC, Campbell LA, Grayston JT. Reactivation of chlamydia pneumoniae lung infection in mice by cortisone Journal of Infectious Diseases. 172: 593-594. PMID 7622914 DOI: 10.1093/Infdis/172.2.593 |
0.433 |
|
| 1995 |
Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. The Journal of Infectious Diseases. 172: 585-8. PMID 7622912 DOI: 10.1093/Infdis/172.2.585 |
0.382 |
|
| 1995 |
Puolakkainen M, Parker J, Kuo CC, Grayston JT, Campbell LA. Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiology and Immunology. 39: 551-4. PMID 7494492 DOI: 10.1111/J.1348-0421.1995.Tb02241.X |
0.32 |
|
| 1994 |
Cappuccio AL, Palton DL, Kuo Cc, Campbell LA. Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: Implications for pathogenesis American Journal of Obstetrics and Gynecology. 171: 102-110. PMID 8030683 DOI: 10.1016/S0002-9378(94)70085-0 |
0.314 |
|
| 1994 |
Melgosa MP, Kuo CC, Campbell LA. Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope Infection and Immunity. 62: 880-886. PMID 7509320 DOI: 10.1128/Iai.62.3.880-886.1994 |
0.409 |
|
| 1993 |
Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. The Journal of Infectious Diseases. 167: 841-9. PMID 8450249 DOI: 10.1093/Infdis/167.4.841 |
0.462 |
|
| 1993 |
Melgosa MP, Kuo CC, Campbell LA. Outer membrane complex proteins of Chlamydia pneumoniae. Fems Microbiology Letters. 112: 199-204. PMID 8405962 DOI: 10.1111/J.1574-6968.1993.Tb06448.X |
0.332 |
|
| 1993 |
Patton DL, Cosgrove YT, Kuo CC, Campbell LA. Effects of quinolone analog CI-960 in a monkey model of Chlamydia trachomatis salpingitis Antimicrobial Agents and Chemotherapy. 37: 8-13. PMID 8381642 DOI: 10.1128/Aac.37.1.8 |
0.376 |
|
| 1993 |
Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. Journal of Clinical Microbiology. 31: 2212-4. PMID 8370753 DOI: 10.1128/Jcm.31.8.2212-2214.1993 |
0.453 |
|
| 1993 |
Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Altman J. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. The Journal of Infectious Diseases. 168: 1231-5. PMID 8228356 DOI: 10.1093/Infdis/168.5.1231 |
0.44 |
|
| 1992 |
Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. Journal of Clinical Microbiology. 30: 434-9. PMID 1537913 DOI: 10.1128/Jcm.30.2.434-439.1992 |
0.417 |
|
| 1991 |
Kornak JM, Kuo CC, Campbell LA. Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog Infection and Immunity. 59: 721-725. PMID 1987088 DOI: 10.1128/Iai.59.2.721-725.1991 |
0.334 |
|
| 1991 |
Melgosa MP, Kuo CC, Campbell LA. Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae Infection and Immunity. 59: 2195-2199. PMID 1840574 DOI: 10.1128/Iai.59.6.2195-2199.1991 |
0.341 |
|
| 1991 |
Kikuta LC, Puolakkainen M, Kuo CC, Campbell LA. Isolation and sequence analysis of the Chlamydia pneumoniae GroE operon Infection and Immunity. 59: 4665-4669. PMID 1682266 DOI: 10.1128/Iai.59.12.4665-4669.1991 |
0.377 |
|
| 1990 |
Campbell LA, Kuo CC, Wang SP, Grayston JT. Serological response to Chlamydia pneumoniae infection Journal of Clinical Microbiology. 28: 1261-1264. PMID 2380354 DOI: 10.1128/Jcm.28.6.1261-1264.1990 |
0.459 |
|
| 1990 |
Campbell LA, Kuo CC, Grayston JT. Structural and antigenic analysis of Chlamydia pneumoniae Infection and Immunity. 58: 93-97. PMID 2294060 DOI: 10.1128/Iai.58.1.93-97.1990 |
0.375 |
|
| 1990 |
Grayston JT, Campbell LA, Kuo C, Mordhorst CH, Saikku P, Thorn DH, Wang S. A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWAR The Journal of Infectious Diseases. 161: 618-625. PMID 2181028 DOI: 10.1093/Infdis/161.4.618 |
0.428 |
|
| 1989 |
Campbell LA, Kuo CC, Thissen RW, Grayston JT. Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans Infection and Immunity. 57: 71-75. PMID 2909493 DOI: 10.1128/Iai.57.1.71-75.1989 |
0.356 |
|
| 1988 |
Cox RL, Kuo CC, Grayston JT, Campbell LA. Deoxyribonucleic acid relatedness of Chlamydia sp. strain TWAR to Chlamydia trachomatis and Chlamydia psittaci International Journal of Systematic Bacteriology. 38: 265-268. DOI: 10.1099/00207713-38-3-265 |
0.339 |
|
| 1987 |
Campbell LA, Kuo CC, Grayston JT. Characterization of the new Clamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization Journal of Clinical Microbiology. 25: 1911-1916. PMID 2822763 DOI: 10.1128/Jcm.25.10.1911-1916.1987 |
0.329 |
|
| Show low-probability matches. |